Phase 1/2a study: Safety and efficacy of new inhibitor in patients with advanced solid and CNS tumors
An early-phase study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine along with other Cancer Centers, suggests that an experimental therapy may have promising ...
May 26, 2023
0
4